精華(hua)制(zhi)(zhi)藥(yao)(yao)集(ji)團股(gu)份有(you)限公(gong)(gong)(gong)司是由南(nan)(nan)(nan)通產控(kong)(kong)(kong)集(ji)團控(kong)(kong)(kong)股(gu)、國(guo)資監(jian)管的地方國(guo)有(you)控(kong)(kong)(kong)股(gu)企業,由原南(nan)(nan)(nan)通中(zhong)(zhong)誠制(zhi)(zhi)藥(yao)(yao)有(you)限公(gong)(gong)(gong)司(南(nan)(nan)(nan)通中(zhong)(zhong)藥(yao)(yao)廠(chang))變(bian)更(geng)、重(zhong)組南(nan)(nan)(nan)通制(zhi)(zhi)藥(yao)(yao)總廠(chang)(南(nan)(nan)(nan)通制(zhi)(zhi)藥(yao)(yao)廠(chang)、南(nan)(nan)(nan)通制(zhi)(zhi)藥(yao)(yao)二廠(chang))優質資源,并吸收民營資本南(nan)(nan)(nan)通綜(zong)藝投資有(you)限公(gong)(gong)(gong)司以及自(zi)然人投資設立。2010年2月(yue)在深交所中(zhong)(zhong)小板掛牌(pai)上市,股(gu)票簡稱:精華(hua)制(zhi)(zhi)藥(yao)(yao),證券代號:002349。
公司(si)(si)已有(you)60多年(nian)的制(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)歷史(shi),是一家綜(zong)合性(xing)的現(xian)代化(hua)GMP制(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)有(you)限(xian)公司(si)(si)。目(mu)前擁有(you)7個(ge)(ge)(ge)(ge)子公司(si)(si),是一家集中(zhong)藥(yao)(yao)(yao)(yao)制(zhi)(zhi)(zhi)劑、中(zhong)藥(yao)(yao)(yao)(yao)飲(yin)片(pian)(pian)、西(xi)藥(yao)(yao)(yao)(yao)制(zhi)(zhi)(zhi)劑、醫藥(yao)(yao)(yao)(yao)中(zhong)間體、化(hua)學原(yuan)料藥(yao)(yao)(yao)(yao)、生物制(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)、保健品等(deng)生產(chan)、銷售和研發的綜(zong)合型制(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)企業集團。公司(si)(si)有(you)中(zhong)西(xi)藥(yao)(yao)(yao)(yao)品種(zhong)200余種(zhong),中(zhong)藥(yao)(yao)(yao)(yao)產(chan)品主(zhu)要(yao)有(you)享譽海內外的經典名藥(yao)(yao)(yao)(yao)“五朵金花”王氏(shi)保赤丸(wan)、季(ji)德(de)勝(sheng)蛇藥(yao)(yao)(yao)(yao)片(pian)(pian)、正柴胡飲(yin)顆(ke)粒、大柴胡顆(ke)粒、金蕎麥膠囊,以(yi)(yi)及固(gu)本咳喘片(pian)(pian)、暈可平糖漿、精血補片(pian)(pian)等(deng),這些中(zhong)藥(yao)(yao)(yao)(yao)品種(zhong)都有(you)著廣泛的歷史(shi)背景及深厚的文化(hua)底蘊,其中(zhong)季(ji)德(de)勝(sheng)蛇藥(yao)(yao)(yao)(yao)片(pian)(pian)、王氏(shi)保赤丸(wan)制(zhi)(zhi)(zhi)作(zuo)技藝均被列入國家非物質(zhi)文化(hua)遺(yi)產(chan)。原(yuan)料藥(yao)(yao)(yao)(yao)產(chan)品主(zhu)要(yao)有(you)苯巴比妥、撲米酮(tong)、氟尿嘧(mi)啶、保泰松、氟胞(bao)嘧(mi)啶、吡羅昔康、替(ti)諾(nuo)昔康、丙硫氧嘧(mi)啶、非那西(xi)丁、雙嘧(mi)達莫以(yi)(yi)及其它醫藥(yao)(yao)(yao)(yao)中(zhong)間體等(deng)。其中(zhong)已有(you)10個(ge)(ge)(ge)(ge)品種(zhong)通過(guo)(guo)國家GMP認(ren)(ren)證(zheng),5個(ge)(ge)(ge)(ge)品種(zhong)通過(guo)(guo)歐盟(meng)CEP認(ren)(ren)證(zheng),2個(ge)(ge)(ge)(ge)品種(zhong)通過(guo)(guo)澳(ao)大利亞GMP認(ren)(ren)證(zheng),3個(ge)(ge)(ge)(ge)品種(zhong)通過(guo)(guo)墨西(xi)哥(ge)官方認(ren)(ren)證(zheng),4個(ge)(ge)(ge)(ge)品種(zhong)獲得美國DMF注冊文件(jian) ,1個(ge)(ge)(ge)(ge)品種(zhong)獲得美國VMF注冊文件(jian),并已通過(guo)(guo)美國FDA現(xian)場核查。
精(jing)華制藥(yao)(yao)(yao)將(jiang)會以(yi)“成為(wei)以(yi)傳世中(zhong)藥(yao)(yao)(yao)為(wei)核心(xin)特(te)色(se)的(de)全國現代醫(yi)藥(yao)(yao)(yao)企業”為(wei)戰略目標,深入貫徹《關于(yu)促進(jin)中(zhong)醫(yi)藥(yao)(yao)(yao)傳承創新發展(zhan)(zhan)的(de)意見(jian)》精(jing)神(shen),聚焦“五朵金花(hua)”傳世中(zhong)藥(yao)(yao)(yao)主業為(wei)主,特(te)色(se)化學原料藥(yao)(yao)(yao)及化學制劑為(wei)輔的(de)“雙輪驅動”的(de)發展(zhan)(zhan)戰略,依托品牌力和渠道力,致力于(yu)成為(wei)以(yi)傳世中(zhong)藥(yao)(yao)(yao)為(wei)核心(xin)特(te)色(se)的(de)全國現代醫(yi)藥(yao)(yao)(yao)企業。